| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner | Director
30 companies
Sandell Scott D is a 10% Owner at SVRA with holdings across 30 companies. Recent SEC Form 4 filings include 2 buys and 27 sells.
Estimated insider holdings value: $1567.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 4, 2023 | CBIO Crescent Biopharma, Inc. | 10% Owner | Sell | 398,133 | $2.98 | $1,185,885.89 | -1.5% | -58.6% | +2.7% | |
| Dec 23, 2022 | ACLX Arcellx, Inc. | 10% Owner | Sell | 390 | $31.67 | $12,352.51 | -100% | -10.0% | +71.3% | |
| Dec 21, 2022 | ACLX Arcellx, Inc. | 10% Owner | Sell | 179 | $30.74 | $5,501.96 | -100% | -3.4% | +67.0% | |
| Jun 14, 2022 | Director | Sell | 2,441 | $40.91 | $99,865.62 | -24.8% | +64.1% | +68.8% | ||
| May 12, 2022 | HOOD Robinhood Markets, Inc. | Director | Sell | 8,792 | $8.41 | $73,940.72 | -100% | +23.6% | +2.1% | |
| May 3, 2022 | HOOD Robinhood Markets, Inc. | Director | Sell | 1,952 | $10.06 | $19,640.44 | -100% | -10.5% | -17.0% | |
| Apr 11, 2022 | TRVI Trevi Therapeutics, Inc. | 10% Owner | Buy | 3,580,526 | $1.90 | $6,802,999.40 | +46.0% | +31.2% | -32.7% | |
| Feb 14, 2022 | Director | Sell | 6,622 | $105.89 | $701,170.58 | -27.6% | -45.7% | -35.2% | ||
| Jan 31, 2022 | HOOD Robinhood Markets, Inc. | Director | Sell | 2,082 | $14.22 | $29,597.71 | -100% | -25.9% | -26.4% | |
| Dec 15, 2021 | ARDX Ardelyx, Inc. | 10% Owner | Sell | 2,856,595 | $1.26 | $3,611,500.32 | -7.9% | -23.4% | +61.7% |